|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 311.30 INR | -4.20% |
|
-6.57% | -10.55% |
| 31/12 | Fermenta Biotech Limited Announces Receiving Order from Central Goods & Services Tax - Mandi Division | CI |
| 10/12 | Fermenta Biotech board approves proposal for raising funds | RE |
| Capitalization | 956.36Cr 10Cr 8.89Cr 8.25Cr 7.74Cr 14Cr 15Cr 94Cr 37Cr 451.76Cr 39Cr 38Cr 1.65TCr | P/E ratio 2024 |
-18.9x | P/E ratio 2025 | 10.4x |
|---|---|---|---|---|---|
| Enterprise value | 1TCr 11Cr 9.3Cr 8.64Cr 8.1Cr 15Cr 16Cr 99Cr 39Cr 472.68Cr 41Cr 40Cr 1.73TCr | EV / Sales 2024 |
1.54x | EV / Sales 2025 | 1.81x |
| Free-Float |
25.97% | Yield 2024 |
0.83% | Yield 2025 | 0.91% |
More valuation ratios
* Estimated data
More news
| 1 day | -4.20% | ||
| 1 week | -6.57% | ||
| Current month | -10.55% | ||
| 1 month | -10.64% | ||
| 3 months | +13.43% | ||
| 6 months | -17.92% | ||
| Current year | -10.55% |
| 1 week | 309 | 343 | |
| 1 month | 309 | 360 | |
| Current year | 309 | 354.5 | |
| 1 year | 219 | 449 | |
| 3 years | 103.3 | 449 | |
| 5 years | 103.3 | 449 | |
| 10 years | 49.17 | 449 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 09/05/2021 | |
Sumesh Gandhi
DFI | Director of Finance/CFO | - | 16/02/2017 |
| Compliance Officer | - | 12/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 44 | 22/06/2011 | |
Rajeshwari Datla
BRD | Director/Board Member | 75 | 29/12/2009 |
| Director/Board Member | 57 | 29/12/2009 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.20% | -6.57% | -22.10% | +77.43% | 10Cr | ||
| +0.82% | +1.83% | +11.10% | +4.64% | 7.75TCr | ||
| -5.07% | +77.80% | +77.80% | +77.80% | 5.62TCr | ||
| +0.68% | +2.33% | -33.47% | -39.80% | 5.88TCr | ||
| -0.08% | -2.56% | +40.81% | +236.02% | 5.78TCr | ||
| +0.68% | +3.10% | +21.75% | -39.18% | 2.55TCr | ||
| +0.37% | -0.17% | +45.09% | +26.27% | 2.06TCr | ||
| +4.14% | +31.78% | +34.73% | -73.26% | 2.03TCr | ||
| +2.83% | -6.48% | +164.45% | +81.17% | 1.81TCr | ||
| +2.25% | +4.79% | +122.96% | +847.92% | 1.54TCr | ||
| Average | +0.25% | +2.60% | +46.31% | +119.90% | 3.5TCr | |
| Weighted average by Cap. | +0.03% | +1.10% | +36.20% | +81.72% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 335.66Cr 3.66Cr 3.12Cr 2.9Cr 2.72Cr 5.06Cr 5.36Cr 33Cr 13Cr 158.56Cr 14Cr 13Cr 580.22Cr | 469.48Cr 5.13Cr 4.36Cr 4.05Cr 3.8Cr 7.07Cr 7.5Cr 46Cr 18Cr 221.77Cr 19Cr 19Cr 811.53Cr |
| Net income | -23Cr -25.18L -21.43L -19.9L -18.66L -34.74L -36.84L -2.27Cr -90.03L -11Cr -94.41L -92.48L -40Cr | 77Cr 83.92L 71.42L 66.33L 62.19L 1.16Cr 1.23Cr 7.57Cr 3Cr 36Cr 3.15Cr 3.08Cr 132.86Cr |
| Net Debt | 79Cr 86.19L 73.36L 68.13L 63.88L 1.19Cr 1.26Cr 7.78Cr 3.08Cr 37Cr 3.23Cr 3.17Cr 136.46Cr | 44Cr 48.34L 41.14L 38.21L 35.83L 66.71L 70.73L 4.36Cr 1.73Cr 21Cr 1.81Cr 1.78Cr 77Cr |
More financial data
* Estimated data
Employees
606
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | 311.30 ₹ | -4.20% | 6,992 |
| 22/26/22 | 324.95 ₹ | -0.32% | 5,040 |
| 21/26/21 | 326.00 ₹ | -1.45% | 8,725 |
| 20/26/20 | 330.80 ₹ | -2.27% | 12,784 |
| 19/26/19 | 338.50 ₹ | +1.59% | 16,596 |
Delayed Quote Bombay S.E., January 23, 2026 at 03:52 pm IST
More quotes- Stock Market
- Equities
- FERMENTA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















